EQNX::TICKER_START (NASDAQ:HELP),(CBOE:HELP),(NYSE:TAK),(NASDAQ:CMPS),(NYSE:PFE),(NYSE:BMY) EQNX::TICKER_END
In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio This news release...
EQNX::TICKER_START (NASDAQ:VWAV),(NYSE:HXL),(NASDAQ:RCAT),(NASDAQ:AVAV),(NYSE:RTX) EQNX::TICKER_END
51% Majority Control of Profitable Aerospace-Certified Composite Platform; Option to Acquire Remaining 49% — $50 Million Independent Valuation West Hollywood, CA – February 24, 2026 — VisionWave...
EQNX::TICKER_START (NASDAQ:VWAV),(NYSE:LHX),(NYSE:RTX),(NASDAQ:RXT),(NASDAQ:PLTR) EQNX::TICKER_END
West Hollywood, CA – February 19, 2026 — VisionWave Holdings, Inc. (Nasdaq: VWAV) today announced it has begun early-stage architecture and feasibility work on a conceptual AI-controlled intelligent...
EQNX::TICKER_START (NASDAQ:ZENA),(NYSE:UAVS),(NYSE:UMAC),(NYSE:NOC),(NASDAQ:PRZO) EQNX::TICKER_END
Vancouver, BC – February 19, 2026 — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as...
EQNX::TICKER_START (NASDAQ:VWAV),(NASDAQ:QUBT),(NYSE:IONQ),(NASDAQ:RGTI),(NYSE:QBTS) EQNX::TICKER_END
Find more press releases from the following organizations